Is Ultraformer FDA-Approved? HIFU Clearance Status & K-Number Verification

High-Intensity Focused Ultrasound (HIFU) has emerged as one of the most sought-after non-surgical treatments for facial lifting, skin tightening, and body contouring. As social media channels like TikTok and Instagram showcase dramatic before-and-after results, and clinic websites aggressively market various HIFU platforms, consumers and medical practitioners are faced with a confusing array of brand names: Ultherapy, Sofwave, Ultraformer III, and Doublo Gold.

Many clinics, particularly outside the United States or within non-traditional medical spas, flatly advertise their platforms as "FDA-approved." However, a rigorous audit of federal regulatory records reveals a stark gap between marketing claims and legal clearance.

For patients and practice owners looking for a direct answer: Ultraformer III (manufactured by Classys) and Doublo Gold (manufactured by Hironic) are NOT FDA-cleared in the United States for facial skin tightening or lifting. Only two focused-ultrasound platforms are FDA-cleared in the US for non-invasive facial lifting and tightening: Ultherapy (since 2009) and Sofwave (since 2021). Classys's SCIZER is cleared under the same focused-ultrasound product code (OHV), but only for non-invasive waist circumference reduction — not facial lifting — so it is a body device, not a face-lifting alternative. Ultraformer has zero US clearances, and Hironic's New Doublo 2.0 received a 2025 clearance under product code GEI for electrosurgery, not ultrasound lifting. Operating or marketing an uncleared HIFU device in the US carries substantial legal, clinical, and liability risks. Always verify a device's 510(k) K-number on the accessdata.fda.gov database before undergoing or offering treatment.

This comprehensive reference breaks down the regulatory classification of ultrasound skin tightening, analyzes the international clearance status of the major HIFU brands, details the product code mismatch of emerging platforms, provides a step-by-step verification guide, and outlines the safety profile documented in federal adverse event databases.

---

The Regulatory Framework: How the FDA Regulates Focused Ultrasound

In the United States, the Food and Drug Administration (FDA) regulates medical devices based on risk. Because focused ultrasound devices emit high-intensity thermal energy deep into subcutaneous tissue layers—which can cause burns, nerve damage, or fat atrophy if misapplied—they are classified as Class II medical devices.

Rather than receiving an "FDA Approval" (which is reserved for high-risk Class III devices via a Premarket Approval or PMA process), energy-based aesthetic devices must secure FDA Clearance through the 510(k) premarket notification pathway. To gain clearance, a manufacturer must prove that their device is "substantially equivalent" to a legally marketed predicate device.

The Critical Product Codes: OHV vs. GEI vs. NGX

When analyzing the regulatory status of a device, the FDA's three-letter product code is the ultimate source of truth. It dictates the legally cleared indications for use and the technological scope of the device.

1. Product Code OHV: This code is titled "Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption." It resides under the Class II classification and is the specific regulatory category required for ultrasound devices cleared for non-invasive skin lifting, tightening, and wrinkles. Predicate devices under this code must undergo rigorous clinical testing to demonstrate that they can safely target the Deep Muscular Aponeurotic System (SMAS) or dermal layers to stimulate collagen synthesis.
2. Product Code GEX / GEI: These codes represent "Electrosurgical, Cutting & Coagulation Devices" and related accessories. Devices cleared under these codes use radiofrequency (RF) currents or electrical energy to cut, coagulate, or ablate tissue. Importantly, a clearance under GEI does not authorize a manufacturer to market their device for focused ultrasound skin lifting, as the mechanism of action, energy delivery, and clinical risk profiles are entirely distinct.
3. Product Code NGX / OAP: These codes represent other light-based and energy-based categories (such as low-level lasers or intense pulsed light). They cannot be used to market a focused ultrasound device.

By searching the U.S. FDA Product Classification Database, we can segment the cleared focused ultrasound landscape. As of our FDA data audit on July 7, 2026, there are only a handful of distinct applicants who have successfully cleared devices under the OHV product code.

---

Which HIFU Skin-Tightening Devices Are Actually FDA-Cleared in the US?

To cut through clinic marketing, it is necessary to identify the specific platforms that hold active FDA clearances under the OHV product code. The following table provides the definitive regulatory status of the leading ultrasound skin-tightening and body contouring devices:

As this database segmentation demonstrates, only Ultherapy and Sofwave are widely available, legally marketed focused-ultrasound devices cleared for non-invasive facial lifting and skin tightening in the United States.

To compare these cleared technologies in detail, read the Ultherapy vs Sofwave vs Thermage comparison. For an analysis of the latest body-specific clearances, refer to the Ultherapy PRIME FDA clearance review.

---

Comparing Regulatory Pathways: US FDA vs. Europe CE MDR vs. Korea MFDS

A common source of confusion is why a device can be legally used in a prestigious London or Seoul clinic but remains banned or restricted in New York. The explanation lies in the fundamental differences between international regulatory pathways.

1. The US FDA 510(k) and De Novo Process

The FDA’s mandate is to establish both safety and efficacy before a device can be marketed. For focused ultrasound, the FDA required a De Novo classification (DEN080006) for the original Ulthera system. This meant the manufacturer had to submit extensive prospective clinical trials demonstrating that the device actually lifted tissue and that the thermal damage was controlled.

Every subsequent device seeking an OHV product code must prove it is "substantially equivalent" in its physical parameters (transducer frequency, power levels, focal depths, thermal profiles) and must submit clinical data. The FDA also conducts rigorous inspections of manufacturing facilities (Quality System Regulation / 21 CFR Part 820).

2. The European Union CE Mark (MDD to MDR)

In Europe, the regulatory framework has historically focused on safety and performance as declared by the manufacturer and verified by a third-party "Notified Body." Under the older Medical Device Directive (MDD), it was relatively easy for manufacturers of aesthetic energy devices to secure a CE mark by demonstrating mechanical safety and citing literature from similar devices (clinical evaluation route).

While the newer Medical Device Regulation (MDR) has significantly tightened these requirements, requiring dedicated clinical trials for Class Ilb aesthetic devices, many platforms like the Ultraformer III hold valid CE marks. However, a CE mark is completely unrecognized by the US FDA.

3. South Korea's Ministry of Food and Drug Safety (MFDS)

South Korea has a highly advanced biotech regulatory framework. The MFDS evaluates devices based on safety, technical parameters, and clinical efficacy. However, the MFDS has a dedicated focus on accelerating domestic technological innovation.

The Ultraformer III has been approved by the MFDS since 2012. The MFDS clearance allows Classys to market the device for facial lifting and tightening within South Korea. However, the manufacturer must still undergo a completely separate, multi-million dollar clinical trial program in the United States to secure an FDA 510(k) under the OHV product code.

---

Is Ultraformer III FDA-Approved — and Why Do Clinics Claim It Is?

Ultraformer III is a highly popular micro- and macro-focused ultrasound (MMFU) device manufactured by Classys, a leading South Korean medical aesthetics firm. It is widely utilized across the European Union (carrying a CE Mark under the European Medical Device Regulation), Australia (TGA listed), South Korea (approved by the Ministry of Food and Drug Safety, or MFDS, since 2012), and over 50 other countries.

However, Ultraformer III is not FDA-cleared in the United States.

The peer-reviewed literature confirms this status. A comprehensive review published in the Journal of Clinical and Aesthetic Dermatology (JCAD / PMC8211327) explicitly states:

"Ultraformer III has been approved by the Korean FDA since 2012, but lacks US FDA clearance."

Why Do Clinics Say It Is Approved?

If you search the web, you will find dozens of medical spa websites in the US, UK, and Asia stating that "Ultraformer III is FDA-approved." This misinformation typically stems from three sources:

1. Conflation of Regulatory Agencies: Marketers often write "FDA-approved" when they actually mean the device is approved by Korea's regulatory agency (the MFDS) or has a CE Mark. While these are reputable regulatory bodies, they do not grant legal marketability in the United States.
2. Parent Company Misdirection: Classys, the manufacturer of Ultraformer, does hold an FDA clearance for a different device: the SCIZER system (510(k) number K230100, cleared on November 3, 2023). The SCIZER uses focused ultrasound, but it is cleared specifically under product code OHV for non-invasive subcutaneous fat reduction in the abdomen. It is not cleared, nor designed, for facial lifting. Unscrupulous marketers take the SCIZER clearance and apply the "FDA-cleared" label to the entire Classys ultrasound portfolio, including the Ultraformer brand.
3. Third-Party OEM Scams: Some gray-market distributors sell cheap, unbranded HIFU machines imported from overseas, labeling them as "Ultraformer" or "FDA-approved HIFU." These devices do not possess K-numbers, classification records, or manufacturing audits.

To understand the broader pathways of international medical devices entering the US market, read our guide on how Korean aesthetic devices enter the US market.

---

Is Doublo Gold FDA-Cleared? The New Doublo 2.0 Product Code Mismatch

Similar to Ultraformer, Doublo Gold (manufactured by Hironic Co., Ltd., South Korea) is a popular international HIFU platform that lacks U.S. FDA clearance.

However, Hironic recently generated headlines in the aesthetic industry by obtaining a 510(k) clearance for their newer platform, the New Doublo 2.0 (also marketed as the DoubleT). Let's examine the primary records to understand what this clearance actually covers.

The 510(k) Bounded Query: K251334

On September 29, 2025, the FDA cleared Hironic’s premarket notification under 510(k) number K251334.

• Applicant: Hironic Co., Ltd.
• Device Name: NEW DOUBLO 2.0 (DoubleT)
• Product Code: GEI
• Classification Name: Electrosurgical, cutting & coagulation device and accessories (21 CFR 878.4400)
• Cleared Indication for Use: General dermatological and surgical procedures for the coagulation of tissue.

This is a classic regulatory-positioning mismatch. The New Doublo 2.0 is marketed internationally as a hybrid platform combining High-Intensity Focused Ultrasound (HIFU) and Radiofrequency (RF) for skin lifting and tightening. However, in the United States, Hironic cleared the device under product code GEI as a basic electrosurgical tissue coagulator.

Why This Product Code Mismatch Matters

If a clinic in the United States purchases a New Doublo 2.0 and markets it for "non-surgical face lifting," "SMAS tightening," or "HIFU brow lifting," they are operating outside the device's FDA-cleared indications.

Because the FDA has not reviewed clinical trial data for the New Doublo 2.0 under the OHV focused-ultrasound code, the device has not legally demonstrated safety or efficacy for deep facial lifting. From a regulatory perspective, calling a GEI-cleared tissue coagulator an "FDA-cleared HIFU lifting device" is misleading and constitutes off-label promotion of an adulterated device.

For a detailed exploration of how device clearances are classified by country, read FDA 510(k) clearances by country.

---

The Physics and Physiology of HIFU vs. MFU: Why It Demands Strict Clearance

Understanding why the FDA treats ultrasound tightening with such caution requires looking at the physics of energy delivery in tissue.

High-Intensity Focused Ultrasound (HIFU) works on the principle of acoustic energy concentration. Similar to using a magnifying glass to focus sunlight onto a single point to create fire, ultrasound transducers focus sound waves into a tiny, localized spot deep within the skin.

The Thermal Coagulation Zone (TCZ)

At the focal point, the rapid vibration of cells generates friction, driving temperatures to 60°C to 70°C in milliseconds. This creates a Thermal Coagulation Zone (TCZ). This localized thermal injury denatures old collagen and initiates a wound-healing response that culminates in the deposition of new, organized collagen over 3 to 6 months.

Transducer Surface
  │   │   │   │   │   (Ultrasound beams enter the skin parallel)
  ▼   ▼   ▼   ▼   ▼
  \   \   │   /   /
   \   \  │  /   /    (Beams focus and converge at a precise depth)
    \   \ │ /   /
     ▼  ▼ ▼ ▼  ▼
        [TCZ]         (Focal point: 60°C - 70°C thermal coagulation zone)
                      (1.5mm: Dermis | 3.0mm: Deep Dermis | 4.5mm: SMAS)

Depending on the cartridge or transducer frequency, these TCZs are placed at different depths:

• 1.5mm (Dermis): Targets superficial wrinkles and skin texture.
• 3.0mm (Deep Dermis/Subcutaneous Fat): Targets dermal tightening and localized fat reduction.
• 4.5mm (SMAS): Targets the Deep Muscular Aponeurotic System. The SMAS is the fibrous, collagen-rich sheath that envelopes the facial muscles. Contracting the SMAS provides the structural "lift" associated with surgical facelifts.

The Critical Need for Real-Time Visualization (MFUV)

The original FDA clearance for Ultherapy was granted because the device utilizes Micro-Focused Ultrasound with Visualization (MFUV). This integrates a real-time diagnostic ultrasound imaging transducer (similar to the technology used to view a fetus) alongside the therapeutic transducer.

Without real-time imaging, the practitioner is performing a "blind" treatment. If the skin thickness varies (which it does significantly across different patients, and even across different areas of the same face), a blind cartridge marked "4.5mm" may deliver energy directly into:

• Facial Bone: Causing severe, radiating pain.
• Blood Vessels: Causing localized hematomas or vascular compromise.
• Motor Nerves: Causing temporary facial paralysis.
• Deep Fat Pockets: Causing permanent fat atrophy and facial hollowing.

This is why the FDA has not granted a blanket clearance to generic HIFU devices. The inclusion of real-time visualization is a primary safety check that prevents energy delivery to critical anatomical structures.

---

Ultraformer vs. Ultherapy vs. Sofwave: What Are the Key Differences?

For patients and clinic operators comparing these technologies, the differences lie in regulatory safety, clinical endpoints, and energy delivery mechanisms.

       [ULTHERAPY]                       [SOFWAVE]                     [ULTRAFORMER III]
• Micro-Focused (MFU)             • Parallel Beam (SUPERB)        • Micro/Macro Focused (MMFU)
• Deep SMAS layer (4.5mm)         • Mid-dermis layer (1.5mm)      • Multi-depth (1.5mm–4.5mm)
• Real-time ultrasound imaging    • Integrated cooling screen     • No real-time imaging
• FDA-Cleared (Lifting)           • FDA-Cleared (Lifting)         • NOT FDA-Cleared in US

1. Ultherapy (Merz Aesthetics)

• Mechanism: Micro-Focused Ultrasound with Visualization (MFUV). It delivers highly concentrated thermal energy at precise depths (typically 1.5mm, 3.0mm, and 4.5mm), reaching all the way to the SMAS layer.
• Unique Feature: Real-time ultrasound imaging. The practitioner can see the tissue layers on a monitor before delivering energy, ensuring they do not target bone, blood vessels, or fat pockets.
• Regulatory Status: Fully FDA-cleared for non-invasive lifting.

2. Sofwave (Sofwave Medical)

• Mechanism: Synchronous Ultrasound Parallel Beam (SUPERB™) technology. Instead of focusing energy into single points, Sofwave projects seven parallel cylinders of ultrasound energy into the mid-dermis (at a fixed depth of 1.5mm).
• Unique Feature: Focuses on the dermis to maximize collagen contraction while utilizing integrated cooling to protect the epidermis. It does not reach the SMAS layer but is less painful than traditional MFU.
• Regulatory Status: Fully FDA-cleared for lifting and wrinkles.

3. Ultraformer III (Classys)

• Mechanism: High-Intensity Focused Ultrasound (HIFU) using exchangeable cartridges for depths ranging from 1.5mm to 4.5mm (facial lifting) and up to 9.0mm (body contouring).
• Unique Feature: Fast repetition rate and dual-engine handpieces, making treatments faster and more comfortable than early-generation Ultherapy.
• Regulatory Status: Not cleared in the US. No real-time visualization, which increases the risk of blind energy delivery when operated by less-experienced technicians.

---

How to Verify a Clinic’s HIFU Device: The K-Number Check

If a medical spa or clinic claims their HIFU device is "FDA-cleared," do not take their word for it. You can verify their claim in under five minutes using the FDA's public databases. Follow this step-by-step verification checklist:

Step 1: Identify the Manufacturer and Model

Ask the clinic for the exact manufacturer name and model of the device they will use. If they refuse to provide this information, treat it as an immediate red flag.

Step 2: Search the FDA 510(k) Database

1. Navigate to the official FDA Premarket Notification 510(k) Database.
2. In the "Applicant Name" field, type the manufacturer (e.g., Ulthera, Sofwave, Classys, or Hironic).
3. Alternatively, type the model name (e.g., SCIZER or New Doublo) into the "Device Name" field.
4. Click Search.

Step 3: Inspect the 510(k) Summary

If a search returns a record, click on the 510(k) number (which starts with a "K"). Look at the document for:

• Product Code: Ensure the product code is OHV if they are marketing it for focused ultrasound facial lifting.
• Indications for Use: Read the cleared text. Does it say "facial lifting," "brow lifting," or does it say "abdominal fat reduction" or "coagulation of tissue"?

Step 4: Check for Predicate Fraud

Confirm that the device in the clinic matches the cleared applicant. Some unauthorized clinics purchase cheap import machines from online marketplaces and display a copy of an Ultherapy 510(k) clearance sheet on their wall, falsely claiming it applies to their machine. The physical brand name on the machine must match the FDA record.

---

Safety Profile: What Are the Risks of Uncleared HIFU Devices?

Focused ultrasound is a highly potent energy source. In the hands of an untrained operator using an uncleared, uncalibrated device, it can cause severe complications. Because these devices heat targeted tissue layers to temperatures between 60°C and 70°C to induce thermal coagulation, any deviation in energy delivery can destroy vital structures.

The 223 MAUDE Reports Analysis

The FDA maintains the Manufacturer and User Facility Device Experience (MAUDE) database, which logs voluntary and mandatory reports of medical device adverse events. An analysis of ultrasound skin-tightening devices in the MAUDE registry (which includes 223 adverse event reports analyzed in our sister-site data) reveals several recurring, severe injuries:

1. Nerve Injury and Temporary Palsy: If ultrasound energy is delivered blindly at a depth of 4.5mm over superficial motor nerves (such as the marginal mandibular branch of the facial nerve), it can cause neurapraxia. Patients in the database reported facial asymmetry, drooping lips, and partial facial paralysis lasting from two weeks to six months.
2. Full-Thickness Skin Burns and Scarring: Uncalibrated devices that deliver energy too superficially, or fail to maintain proper transducer coupling with the skin, can cause epidermal burns. This results in painful linear blistering, hypopigmentation, hyperpigmentation, and permanent atrophic scarring.
3. Subcutaneous Fat Atrophy: When focused ultrasound is delivered to thin faces at inappropriate depths, it can permanently destroy subcutaneous fat cells. Patients reported a "hollowed," prematurely aged appearance, requiring corrective dermal fillers or fat grafting.
4. Ocular Damage: Treatments performed too close to the orbital rim without shielding can lead to iris atrophy, cataracts, or permanent vision impairment due to ultrasound energy penetrating the globe.

To review these specific clinical case studies and learn how to manage complications, read our dedicated analysis on ultrasound skin tightening MAUDE injuries.

---

Practice Operator Workflow: Sourcing and Siting Guidelines

For aesthetic clinic owners and operators, adding a new energy-based device is a complex business and legal decision. If you are considering adding focused ultrasound to your treatment menu, follow this regulatory sourcing workflow to protect your business:

[Is the manufacturer BLA/510(k) cleared under product code OHV for lifting?]
         ├── YES ──> [Purchase from authorized US distributor only]
         └── NO  ──> [STOP. Do not purchase or import into the US]

1. Inspect the Import Trail: Under the Federal Food, Drug, and Cosmetic Act, any device imported into the US that lacks a valid 510(k) clearance for its intended use is considered "adulterated" and "misbranded." U.S. Customs and Border Protection (CBP) works alongside the FDA to seize unauthorized medical devices at ports of entry. If you purchase an Ultraformer III from an overseas broker, you risk having the machine seized, losing your entire deposit.
2. Verify State Medical Board Delegation Rules: Focused ultrasound is considered a medical procedure. State medical boards regulate who can perform energy-based device treatments. In states like California and Texas, energy-based skin tightening is classified as a medical treatment that can only be delegated to registered nurses (RNs), physician assistants (PAs), or nurse practitioners (NPs) under physician supervision. Unlicensed estheticians are legally prohibited from operating these devices. Operating an uncleared device under improper delegation is a dual violation that can result in the suspension of the medical director's license.
3. Audit Your Malpractice Insurance Policy: Contact your professional liability insurance broker before offering treatment. Most malpractice carriers require you to submit the manufacturer name and model of any energy-based device. If you list an uncleared device, or if the insurer discovers that a complication resulted from a device lacking FDA clearance for that indication, they will deny coverage, leaving your practice personally liable for any damages.

---

FAQs: Clear Answers on HIFU Regulations

If Ultraformer is used in 55 countries and CE-marked, why isn’t it FDA-cleared?

The FDA has its own specific testing, clinical trial, and manufacturing audit requirements that differ from the European Union's CE marking and South Korea’s MFDS. Gaining FDA clearance is an expensive, multi-year process. If a manufacturer does not believe the US market opportunity justifies the cost of a full clinical trial for a specific device, or if they prefer to sell a different device in the US (such as Classys selling the SCIZER for body contouring), they may choose not to pursue clearance for their flagship facial lifting platform.

My US clinic says their device is "FDA-approved HIFU" — how can that be wrong?

They are likely using "FDA-approved" as a loose, unauthorized marketing buzzword. They might be using a US-cleared platform like Ultherapy or Sofwave, but they are mislabeling it as generic "HIFU." Alternatively, they may be using an uncleared import machine (like Ultraformer III or Doublo Gold) and falsely applying the FDA-cleared status of Ultherapy or Classys's SCIZER to their unauthorized device.

Can a practice legally import Ultraformer or Doublo Gold for off-label use?

No. In the United States, it is a violation of the Federal Food, Drug, and Cosmetic Act to import, introduce, or deliver into interstate commerce a medical device that is misbranded or adulterated. An energy-based device that lacks a 510(k) clearance or PMA for its marketed indications is legally considered adulterated. Importing such a device, even if intended for "off-label" clinical use, can result in customs seizures, FDA warning letters, civil penalties, and the loss of the practitioner's medical license.

What are the liability risks for a practitioner using an uncleared device?

Using an uncleared medical device exposes a practice to severe liability. Medical malpractice insurance policies typically exclude coverage for procedures performed with unapproved or uncleared medical devices. If a patient suffers a burn or nerve injury from an uncleared HIFU machine, the practitioner may face personal financial liability, lawsuits, and disciplinary action from their state medical board.

Can I buy a CE-marked device and use it in a US clinic?

No. A CE mark only grants authorization to sell and use a device within the European Economic Area (EEA) and other countries that recognize European standards. It holds no legal weight in the United States. Under federal law, any medical device used in a US clinic must be cleared or approved by the US FDA.

---

Sources

• U.S. Food and Drug Administration. (2026). 510(k) Premarket Notification Database. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
• U.S. Food and Drug Administration. (2026). Product Classification Database (Product Code: OHV, GEI). Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm
• U.S. Food and Drug Administration. (2025). 510(k) Premarket Notification K251334: NEW DOUBLO 2.0 (DoubleT). Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K251334
• U.S. Food and Drug Administration. (2023). 510(k) Premarket Notification K230100: SCIZER (SC1-M410). Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K230100
• Fabi, S. G., et al. (2021). Customized Treatment Using Microfocused Ultrasound with Visualization for Skin Laxity: A Review of the Literature and Clinical Practice Guidelines. The Journal of Clinical and Aesthetic Dermatology, 14(6 Suppl 1), S4–S11. PMC8211327
• Classys Inc. (2023). Classys SCIZER and Ultraformer Product Specifications. Retrieved from https://www.classysglobal.com
• Hironic Co., Ltd. (2025). NEW DOUBLO 2.0 and Doublo Gold Regulatory Profiles. Retrieved from https://hironic.com
• American Academy of Dermatology. (2025). Laser and energy-based device safety guidelines. Retrieved from https://www.aad.org
• U.S. Food and Drug Administration. (2026). Manufacturer and User Facility Device Experience (MAUDE) Database. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM